Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exhaled Breath Particles as Biomarkers for Diagnosing, Prognosticating and Evaluating of Non Small Cell Lung Cancer

NCT05395611 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT05395611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exhaled Breath Particles as Biomarkers for Diagnosing, Prognosticating and Evaluating of Non Small Cell Lung Cancer
Lead sponsor
Lund University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 23, 2018
Completion date
January 31, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma, lung cancer, non-small cell lung cancer, squamous cell lung cancer